Related Experiment Video
Updated: May 19, 2026
11:48
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Small interfering RNAs targeting the rabies virus nucleoprotein gene
Yu-Jiao Yang1, Ping-Sen Zhao, Tao Zhang
1Agricultural Division, College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, Jilin Province, China.
Virus Research
|August 14, 2012
Summary
New RNA interference (RNAi) therapies show promise for rabies treatment. Three small interfering RNAs (siRNAs) effectively inhibited rabies virus (RABV) replication in vitro and in vivo, increasing survival rates in infected mice.
Area of Science:
- Virology
- Molecular Biology
- Therapeutics
Background:
- Rabies virus (RABV) poses a significant global health risk with no existing cure.
- RNA interference (RNAi) therapy offers a potential strategy for treating viral infections by silencing specific genes.
Purpose of the Study:
- To design and evaluate small interfering RNAs (siRNAs) targeting the RABV nucleoprotein (N) gene for therapeutic potential.
- To assess the efficacy of novel siRNAs in inhibiting RABV replication both in vitro and in vivo.
Main Methods:
- Six siRNAs targeting the conserved region of the RABV CVS-11 N gene were designed.
- In vitro efficacy was tested using plasmid-based expression models and infected baby hamster kidney-21 (BHK-21) cells.
- In vivo efficacy was evaluated in RABV-infected mice using liposome-mediated delivery of siRNA expression plasmids.
Main Results:
- Three siRNAs (N796, N580, and N799) demonstrated significant inhibition of RABV replication.
- Suppression of RABV expression was confirmed by immunofluorescence, viral titer, real-time PCR, and Western blotting in BHK-21 cells.
- Liposome-mediated delivery of siRNA expression plasmids in mice significantly improved survival rates.
Conclusions:
- The siRNAs N796, N580, and N799 effectively inhibit RABV CVS-11 replication.
- These siRNAs represent promising candidates for the development of novel prophylactic anti-rabies drugs.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...